Popular on EntSun
- UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 264
- Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 224
- Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick - 169
- "I Make Music Not Excuses" Journal by Anthony Clint Jr. Becomes International Amazon Best Seller, Empowering Music Creators Worldwide - 163
- Crunchbase Ranks Phinge Founder & CEO Robert DeMaio #1 Globally. Meet him in Las Vegas-Week of CES to Learn About Netverse, Patented App-less Platform - 157
- "Micro-Studio": Why San Diegans are Swapping Crowded Gyms for Private, One-on-One Training at Sweat Society - 143
- VDG Virtuoso Emerges as a New-Model Independent Industry Figure Blending Artist, Executive, and Infrastructure Builder - 132
- Phillip E. Walker's Hollywood Actor Jobs Dec. 10-20, 2025 PRE-TOUR Launches with SweetestVacation.com at CulverCityFilmFestival.com & Closes in the IE - 126
- Donna Cardellino Manager/Facilitator Signs Justin Jeansonne Country Singer-Songwriter To Exclusive Management Deal For Global Music Expansion - 126
- Contracting Resources Group Receives 2025 HIRE Vets Platinum Medallion Award from the U.S. Department of Labor - 115
Similar on EntSun
- Global License Exclusive Secured for Emesyl OTC Nausea Relief, Expanding Multi-Product Growth Strategy for Caring Brands, Inc. (N A S D A Q: CABR)
- RNHA Affirms Support for President Trump as Nation Marks Historic Victory for Freedom
- American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
- $140 to $145 Million in 2026 Projected and Profiled in New BD Deep Research Report on its Position in $57 Billion US Marine Industry; N Y S E: OTH
- Graduates With $40K in Student Debt Are Buying Businesses Instead of Taking Entry-Level Jobs
- How Democrats Made Healthcare More Expensive in 2026
- FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
- Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
- Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
- AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
VSee Health (N A S D A Q: VSEE) Secures $6.0M At-Market Investment, Accelerates Expansion as Revenues Surge
EntSun News/11079897
VSee Health, Inc. (N A S D A Q: VSEE) $VSEE Reported Q3 Revenues Reach $3.98 Million, Up 19% Year-Over-Year with Clients Including NASA, U.S. Department of Health and Human Services, McKesson, DaVita and The Nation of Qatar
NEWTON, Mass. - EntSun -- VSee Health, Inc. (N A S D A Q: VSEE), a rapidly scaling telehealth technology leader, continues to strengthen its growth trajectory following a $6.0 million private placement priced at-market, rising revenues, and a growing roster of high-profile healthcare, government, and enterprise clients. With expanding multi-year contracts, federal authorizations, and AI-powered innovation, VSee is positioning itself at the forefront of the global digital health transformation.
Strong Financial Momentum and Expanding Revenue Base
$VSEE reported Q3 2025 revenues of $3.98 million, representing 19% year-over-year growth, driven by increased adoption of its integrated telehealth platform and professional services. For the first nine months of 2025, revenues reached $10.69 million, up 60% compared to the same period in 2024, reflecting the full contribution of its iDoc acquisition and accelerating hospital partnerships.
Gross margins remained healthy at 52%, supporting scalable growth as VSee continues to execute on a pipeline of multi-year contracts expected to add millions in annual recurring revenue.
$6.0 Million Institutional Investment Strengthens Balance Sheet
On November 26, VSee announced a $6.0 million private placement with a single institutional investor, priced at an effective combined price of $0.61 per share, in line with market pricing. The capital infusion strengthens VSee's balance sheet and supports ongoing expansion initiatives across telehealth, teleradiology, and federal healthcare markets.
The financing underscores institutional confidence in VSee's long-term strategy, technology platform, and expanding revenue visibility.
AI-Powered, Modular Telehealth Platform Driving Differentiation
VSee's platform is designed as "Lego-like" digital health building blocks, allowing hospitals, governments, and enterprises to rapidly deploy customized telehealth systems without extensive development resources. Its no-code / low-code architecture, seamless EHR integrations, advanced data visualization, and enterprise-grade security provide flexibility and scalability for evolving healthcare needs.
More on EntSun News
A recent innovation, AI Doctor Notes, reduces clinical documentation time by up to 93%, directly addressing physician burnout and operational inefficiencies—key pain points across healthcare systems.
Trusted by Global Healthcare and Government Leaders
VSee's technology supports more than 1,000 clients worldwide, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, Magellan, GE, and the entire nation of Qatar. The platform handles over 1.5 million HIPAA-compliant video encounters per month and has been deployed in more than 50 countries, including underserved and remote regions.
The company also serves critical shortage areas such as critical care and teleradiology, positioning VSee as an essential infrastructure provider rather than a single-use telehealth vendor.
Major Contract Wins and iDoc Division Execution
VSee's iDoc division continues to deliver on previously announced contracts, contributing meaningfully to revenue growth:
These wins validate VSee's ability to deploy quickly at scale and integrate seamlessly into complex hospital systems.
Multi-Year Agreements and Scalable Revenue Models
In November, VSee secured a three-year platform services agreement with the sole Level 1 Trauma Center and leading academic health system in its metropolitan region. The volume-based, uncapped reimbursement structure enables revenue to scale directly with utilization across more than 100 hospitals and outpatient sites, with services launching January 1, 2026.
Federal Expansion and Robotics Integration
VSee recently achieved FedRAMP High Authority to Operate (ATO) from the U.S. Department of Health & Human Services, enabling deployment across federal agencies requiring the highest security standards. This authorization significantly expands VSee's addressable market.
More on EntSun News
The company is also integrating robotic telepresence solutions through its partnership with Ava Robotics, bringing remote clinician coverage into ICU settings—an innovation with the potential to transform critical care delivery.
Strategic Partnerships and Global Growth Initiatives
Beyond the U.S., VSee is pursuing expansion opportunities in Southeast Asia, engaging Philippine health leaders and former Vice President Leni Robredo to explore digital health initiatives. Strategic partnerships, including AbundaLife™, address long-standing healthcare challenges such as fragmented medical records.
Thought Leadership and Webinar with Novant Health Urgent Care
VSee recently announced a webinar with Novant Health Urgent Care, the largest urgent care provider in South Carolina, focused on building scalable, profitable virtual urgent care programs. Hosted by VSee Co-CEO Dr. Milton Chen and Novant Health's Director of Telemedicine, the event highlights VSee's role in enabling branded, efficient, and financially sustainable telehealth operations.
Positioned for a $200+ Billion Market Opportunity
With the global telehealth market projected to exceed $200 billion by 2030, VSee Health stands out as a field-tested, enterprise-grade platform with demonstrated traction, recurring revenue visibility, and expanding institutional adoption.
Backed by recent funding, growing contracts, and differentiated AI-driven technology, VSee Health continues to execute on a strategy aimed at long-term value creation in one of healthcare's fastest-growing sectors.
📈 Why VSee (N A S D A Q: VSEE) Deserves Investor Attention
VSee is more than just a telehealth platform—it's an engine of innovation powering the digital transformation of healthcare worldwide. With recurring revenue growth, major federal and global clients, AI-driven solutions, and a continued Nasdaq listing, VSEE is positioning itself for long-term, scalable success in a market expected to exceed $504 billion by 2030.
For more information on $VSEE visit: www.vseehealth.com
Media Contact:
Company Name: VSee Health (N A S D A Q: VSEE)
Contact: Milton Chen
Email: investor@vsee.com
Phone: 626-513-1824
Country: United States
Website: www.vseehealth.com
DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website
Building the Future of Healthcare, One Digital Block at a Time.
Strong Financial Momentum and Expanding Revenue Base
$VSEE reported Q3 2025 revenues of $3.98 million, representing 19% year-over-year growth, driven by increased adoption of its integrated telehealth platform and professional services. For the first nine months of 2025, revenues reached $10.69 million, up 60% compared to the same period in 2024, reflecting the full contribution of its iDoc acquisition and accelerating hospital partnerships.
Gross margins remained healthy at 52%, supporting scalable growth as VSee continues to execute on a pipeline of multi-year contracts expected to add millions in annual recurring revenue.
$6.0 Million Institutional Investment Strengthens Balance Sheet
On November 26, VSee announced a $6.0 million private placement with a single institutional investor, priced at an effective combined price of $0.61 per share, in line with market pricing. The capital infusion strengthens VSee's balance sheet and supports ongoing expansion initiatives across telehealth, teleradiology, and federal healthcare markets.
The financing underscores institutional confidence in VSee's long-term strategy, technology platform, and expanding revenue visibility.
AI-Powered, Modular Telehealth Platform Driving Differentiation
VSee's platform is designed as "Lego-like" digital health building blocks, allowing hospitals, governments, and enterprises to rapidly deploy customized telehealth systems without extensive development resources. Its no-code / low-code architecture, seamless EHR integrations, advanced data visualization, and enterprise-grade security provide flexibility and scalability for evolving healthcare needs.
More on EntSun News
- American Laser Study Club Announces 2026 Kumar Patel Prize in Laser Surgery Recipients: Ann Bynum, DDS, and Boaz Man, DVM
- Lineus Medical Completes UK Registration for SafeBreak® Vascular
- Creators' Rights Movement Advances Copyright Rights and Generational Ownership
- Canyons & Chefs Announces Revamped Homepage
- $140 to $145 Million in 2026 Projected and Profiled in New BD Deep Research Report on its Position in $57 Billion US Marine Industry; N Y S E: OTH
A recent innovation, AI Doctor Notes, reduces clinical documentation time by up to 93%, directly addressing physician burnout and operational inefficiencies—key pain points across healthcare systems.
Trusted by Global Healthcare and Government Leaders
VSee's technology supports more than 1,000 clients worldwide, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, Magellan, GE, and the entire nation of Qatar. The platform handles over 1.5 million HIPAA-compliant video encounters per month and has been deployed in more than 50 countries, including underserved and remote regions.
The company also serves critical shortage areas such as critical care and teleradiology, positioning VSee as an essential infrastructure provider rather than a single-use telehealth vendor.
Major Contract Wins and iDoc Division Execution
VSee's iDoc division continues to deliver on previously announced contracts, contributing meaningfully to revenue growth:
- Two new hospitals now live on the iDoc platform, expected to generate $500,000 in annual revenue
- 21 of 34 hospitals activated in a major teleradiology network, with additional rollouts scheduled in early 2026
- A $10+ million multi-year teleradiology contract with a premier Level 1 hospital system is projected to double annual recurring revenue
- Additional proposals submitted totaling $3 million in potential contract value
These wins validate VSee's ability to deploy quickly at scale and integrate seamlessly into complex hospital systems.
Multi-Year Agreements and Scalable Revenue Models
In November, VSee secured a three-year platform services agreement with the sole Level 1 Trauma Center and leading academic health system in its metropolitan region. The volume-based, uncapped reimbursement structure enables revenue to scale directly with utilization across more than 100 hospitals and outpatient sites, with services launching January 1, 2026.
Federal Expansion and Robotics Integration
VSee recently achieved FedRAMP High Authority to Operate (ATO) from the U.S. Department of Health & Human Services, enabling deployment across federal agencies requiring the highest security standards. This authorization significantly expands VSee's addressable market.
More on EntSun News
- Bay Street Yard to host 'Charitable Pour' bourbon pairing dinner Jan. 21
- Really Cool Music Releases Its Fourth Single - "So Many Lost Years"
- MGN Logistics Acquires Fast Service LLC, Fueling MyMGN Marketplace Expansion and Supercharging Expedited Coverage Nationwide
- The Wait is Over: Salida Wine Festival Announces Triumphant 2026 Return After Seven-Year Hiatus
- Graduates With $40K in Student Debt Are Buying Businesses Instead of Taking Entry-Level Jobs
The company is also integrating robotic telepresence solutions through its partnership with Ava Robotics, bringing remote clinician coverage into ICU settings—an innovation with the potential to transform critical care delivery.
Strategic Partnerships and Global Growth Initiatives
Beyond the U.S., VSee is pursuing expansion opportunities in Southeast Asia, engaging Philippine health leaders and former Vice President Leni Robredo to explore digital health initiatives. Strategic partnerships, including AbundaLife™, address long-standing healthcare challenges such as fragmented medical records.
Thought Leadership and Webinar with Novant Health Urgent Care
VSee recently announced a webinar with Novant Health Urgent Care, the largest urgent care provider in South Carolina, focused on building scalable, profitable virtual urgent care programs. Hosted by VSee Co-CEO Dr. Milton Chen and Novant Health's Director of Telemedicine, the event highlights VSee's role in enabling branded, efficient, and financially sustainable telehealth operations.
Positioned for a $200+ Billion Market Opportunity
With the global telehealth market projected to exceed $200 billion by 2030, VSee Health stands out as a field-tested, enterprise-grade platform with demonstrated traction, recurring revenue visibility, and expanding institutional adoption.
Backed by recent funding, growing contracts, and differentiated AI-driven technology, VSee Health continues to execute on a strategy aimed at long-term value creation in one of healthcare's fastest-growing sectors.
📈 Why VSee (N A S D A Q: VSEE) Deserves Investor Attention
VSee is more than just a telehealth platform—it's an engine of innovation powering the digital transformation of healthcare worldwide. With recurring revenue growth, major federal and global clients, AI-driven solutions, and a continued Nasdaq listing, VSEE is positioning itself for long-term, scalable success in a market expected to exceed $504 billion by 2030.
For more information on $VSEE visit: www.vseehealth.com
Media Contact:
Company Name: VSee Health (N A S D A Q: VSEE)
Contact: Milton Chen
Email: investor@vsee.com
Phone: 626-513-1824
Country: United States
Website: www.vseehealth.com
DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website
Building the Future of Healthcare, One Digital Block at a Time.
Source: CorporateAds
Filed Under: Health
0 Comments
Latest on EntSun News
- Upcoming Movies: 360 Sound And Vision Releases It's Slate Of Movies For 2026
- Waliin Completes First Community Fundraising Round and Unveils Major Platform Expansion
- Obey God Clothing Launches Urban Christian Apparel Line Serving All Ages
- Is Rolex the Best Watch Ever Made? Experts Weigh In
- Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
- PowerTribe Releases New Heavy Metal Single "The Earthlings Have Died"
- Australian Soulstress NARDIA returns to the U.S. for her January 2026 Tour
- Lacy Hendricks Earns Prestigious MPM® Designation from NARPM®
- Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
- AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
- IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
- AI-Driven Trailer Launches for Dystopian Sci-Fi Thriller JoinWith.Me
- Are You Hiring The Right Heater Repair Company in Philly?
- Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
- Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
- Elklook Launches 2026 New Year Promotion
- Godspell Comes To The Elks Lodge In Culver City, California
- OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
- DMV HOTTEST Announces Strategic Partnership with the National "Coast to Coast Countdown" for New Year's Eve 2025
- Indie Film Takes a Bite out of Horror, Sprinkled with a Dash of Dark Humor and Social Commentary




